Onco Wiki / Bandeira vermelha

Baseline organ dysfunction precluding doxorubicin / ifosfamide-based chemotherapy in dedi...

Visão determinística da entidade fonte YAML. A autoridade clínica permanece com os IDs de fonte citados e estado de assinatura do revisor.

IDRF-CHONDROSARCOMA-ORGAN-DYSFUNCTION
TipoSinal de alerta
Estadoreviewed 2026-04-27 | pending_clinical_signoff
DoençasDIS-CHONDROSARCOMA
FontesSRC-ESMO-BONE-SARCOMA SRC-NCCN-BONE-SARCOMA

Origem da bandeira vermelha

DefiniçãoBaseline organ dysfunction precluding doxorubicin / ifosfamide-based chemotherapy in dedifferentiated or mesenchymal chondrosarcoma: LVEF <50% (anthracycline contraindicated), CrCl <30 mL/min (ifosfamide nephrotoxicity, MESNA dose constraints), bilirubin >3× ULN (anthracycline metabolism), or DLCO <60% (post-thoracotomy pulmonary reserve concern for surgical resection of pulmonary metastases).
Direcção clínicade escalonamento
Categoriadisfunção de órgãos

Lógica de Desencadeamento

{
  "any_of": [
    {
      "comparator": "<",
      "finding": "lvef_percent",
      "threshold": 50
    },
    {
      "comparator": "<",
      "finding": "creatinine_clearance_ml_min",
      "threshold": 30
    },
    {
      "comparator": ">=",
      "finding": "bilirubin_ratio_to_uln",
      "threshold": 3
    },
    {
      "comparator": "<",
      "finding": "dlco_percent",
      "threshold": 60
    }
  ],
  "type": "lab_value"
}

Notas

Conventional chondrosarcoma is largely chemo-resistant; the organ- dysfunction flag matters for dedifferentiated subtype (10%) where doxorubicin + ifosfamide adjuvant is extrapolated from soft-tissue sarcoma protocols, and mesenchymal subtype (3-5%) treated with Ewing- type VDC/IE — both anthracycline + alkylator-heavy. LVEF <50: omit doxorubicin or substitute liposomal formulation (limited data). CrCl <30: ifosfamide contraindicated — switch to dose-modified doxorubicin monotherapy or pazopanib for advanced disease. DLCO <60: limits metastasectomy candidacy, important for oligometastatic pulmonary disease.

Usado por

Não há referências reversas encontradas no corpus YAML.